The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGYG.L Regulatory News (GYG)

  • There is currently no data for GYG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

5 Oct 2021 12:28

RNS Number : 0858O
Singer Capital Markets Sec Ltd
05 October 2021
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Singer Capital Markets Securities Ltd

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

GYG PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

GYG PLC

(d) Date dealing undertaken:

04 October 2021

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

If YES, specify which:

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 0.002P

 

 

Sale

 

10,000

 

65.9p

 

65.9p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

05 October 2021

Contact name:

Sarah-Rose Perry, Jennifer Bentick

Telephone number:

020 7496 3093

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERUVUARANURRAA
Date   Source Headline
9th Dec 20193:09 pmRNSHolding(s) in Company
9th Dec 20197:00 amRNSHolding(s) in Company
4th Dec 20194:25 pmRNSTR-1: Standard form notification of major holdings
17th Oct 20197:00 amRNSDirector/PDMR's Dealing
16th Oct 20192:30 pmRNSTR-1: Standard form notification of major holdings
16th Oct 20192:24 pmRNSTR-1: Standard form notification of major holdings
16th Oct 20197:00 amRNSPDMR Dealing
15th Oct 20198:59 amRNSTR-1: Standard form notification of major holdings
14th Oct 20192:50 pmRNSHolding(s) in Company
11th Oct 20192:06 pmRNSSecond Price Monitoring Extn
11th Oct 20192:00 pmRNSPrice Monitoring Extension
11th Oct 201911:47 amRNSHolding(s) in Company
26th Sep 20197:00 amRNSNew Build Contract Wins
26th Sep 20197:00 amRNSInterim Results
19th Sep 20197:00 amRNSBoard Change - CFO Appointment
31st Jul 20197:00 amRNSTrading Update and Board Change
10th Jul 20197:46 amRNSHolding(s) in Company
8th Jul 20194:20 pmRNSHolding(s) in Company
23rd May 201912:19 pmRNSResult of AGM
21st May 20197:00 amRNSTrading Update
17th Apr 20197:00 amRNSNotice of AGM
5th Apr 20197:00 amRNSGrant of Options
4th Apr 20197:00 amRNSFinal Results
26th Mar 20197:00 amRNSNew Build Contract Wins
28th Jan 20194:40 pmRNSSecond Price Monitoring Extn
28th Jan 20194:35 pmRNSPrice Monitoring Extension
25th Jan 20197:07 amRNSHolding(s) in Company
23rd Jan 20194:52 pmRNSHolding(s) in Company
22nd Jan 20197:00 amRNSFull Year Trading Update
3rd Jan 201910:25 amRNSHolding(s) in Company
20th Dec 20184:08 pmRNSHolding(s) in Company
16th Nov 20184:01 pmRNSPDMR Dealing
14th Nov 20184:17 pmRNSHolding(s) in Company
12th Nov 20187:00 amRNSDirector/PDMR Shareholding
31st Oct 20184:40 pmRNSSecond Price Monitoring Extn
31st Oct 20184:35 pmRNSPrice Monitoring Extension
31st Oct 20182:05 pmRNSSecond Price Monitoring Extn
31st Oct 20182:00 pmRNSPrice Monitoring Extension
31st Oct 20187:00 amRNSTrading Update
20th Sep 20187:00 amRNSInterim Results
24th Jul 20184:35 pmRNSHolding(s) in Company
18th Jul 20184:10 pmRNSHolding(s) in Company
18th Jul 20183:01 pmRNSHolding(s) in Company
18th Jul 201810:17 amRNSPDMR Director Dealing
17th Jul 20184:40 pmRNSSecond Price Monitoring Extn
17th Jul 20184:35 pmRNSPrice Monitoring Extension
16th Jul 20183:47 pmRNSHolding(s) in Company
13th Jul 20185:02 pmRNSDirectors' Dealings
13th Jul 20183:02 pmRNSHolding(s) in Company
13th Jul 20182:11 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.